Immune checkpoint molecules soluble program death ligand 1 and galectin-9 are increased in pregnancy
American Journal of Reproductive Immunology Dec 07, 2017
Enninga EAL, et al. - Given a high involvement of soluble program death ligand-1 (sPD-L1) and galectin-9 in immune suppression during cancer, these molecules were assessed in the blood samples from pregnant women during gestation. Researchers noted that during pregnancy, immune-regulatory molecules galectin-9 and sPD-L1 increased. Furthermore, these molecules may play a role in immune tolerance that is important for the fetus.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries